Teligent Other Long-Term Assets 2010-2021 | TLGT

Teligent other long-term assets from 2010 to 2021. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Teligent Annual Other Long-Term Assets
(Millions of US $)
2020 $4
2019 $4
2018 $2
2017 $1
2016 $1
2015 $0
2014 $6
2013 $2
2012 $0
2011 $1
2010 $1
2009 $0
Teligent Quarterly Other Long-Term Assets
(Millions of US $)
2021-06-30 $3
2021-03-31 $4
2020-12-31 $4
2020-09-30 $4
2020-06-30 $4
2020-03-31 $3
2019-12-31 $4
2019-09-30 $4
2019-06-30 $4
2019-03-31 $4
2018-12-31 $2
2018-09-30 $1
2018-06-30 $1
2018-03-31 $1
2017-12-31 $1
2017-09-30 $1
2017-06-30 $1
2017-03-31 $1
2016-12-31 $1
2016-09-30 $4
2016-06-30 $4
2016-03-31 $4
2015-12-31 $0
2015-09-30 $17
2015-06-30 $17
2015-03-31 $18
2014-12-31 $6
2014-09-30 $10
2014-06-30 $2
2014-03-31 $2
2013-12-31 $2
2013-09-30 $2
2013-06-30 $2
2013-03-31 $2
2012-12-31 $0
2012-09-30 $0
2012-06-30 $1
2012-03-31 $1
2011-12-31 $1
2011-09-30 $1
2011-06-30 $1
2011-03-31 $1
2010-12-31 $1
2010-09-30 $0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31 $1
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $24.935B 8.18
Dr Reddy's Laboratories (RDY) India $12.596B 24.10
BridgeBio Pharma (BBIO) United States $6.773B 0.00
Bausch Health Cos (BHC) Canada $2.792B 2.06
Supernus Pharmaceuticals (SUPN) United States $2.108B 28.70
Amphastar Pharmaceuticals (AMPH) United States $1.738B 10.44
Personalis (PSNL) United States $0.396B 0.00
Taysha Gene Therapies (TSHA) United States $0.314B 21.86
Assembly Biosciences (ASMB) United States $0.095B 0.00
Sol-Gel Technologies (SLGL) Israel $0.025B 0.00
Evoke Pharma (EVOK) United States $0.006B 0.00